Alkermes Announces Webcast of Analyst and Investor Event on September 26, 2016
September 19 2016 - 4:00PM
Business Wire
Alkermes plc (NASDAQ: ALKS) announced today that it will webcast
its Analyst and Investor Event presentation on Monday, September
26, 2016. The webcast will begin at 2:00 p.m. EDT (7:00 p.m. BST).
At the event, members of Alkermes’ senior management will provide
an overview of medical, commercial, policy and market perspectives
for VIVITROL® (naltrexone for extended-release injectable
suspension).
A live webcast of the event will be available on the Investors
section of the company’s website at www.alkermes.com. To ensure a
timely connection to the webcast, it is recommended that users
register at least 15 minutes prior to the scheduled start. This
webcast will be archived on the Investors section of the company’s
website at www.alkermes.com for one month following the
presentation.
Alkermes plc is a fully integrated, global
biopharmaceutical company developing innovative medicines for the
treatment of central nervous system (CNS) diseases. The company has
a diversified commercial product portfolio and a substantial
clinical pipeline of product candidates for chronic diseases that
include schizophrenia, depression, addiction and multiple
sclerosis. Headquartered in Dublin, Ireland, Alkermes plc has an
R&D center in Waltham, Massachusetts; a research and
manufacturing facility in Athlone, Ireland; and a manufacturing
facility in Wilmington, Ohio. For more information, please visit
Alkermes’ website at www.alkermes.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160919006058/en/
Alkermes plcJennifer Zibuda, +1 781-609-6129Corporate
Communications
Alkermes (NASDAQ:ALKS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Alkermes (NASDAQ:ALKS)
Historical Stock Chart
From Sep 2023 to Sep 2024